Skip to main content
. 2009 Aug 1;80(4):402–412. doi: 10.3109/17453670903161124

Table 5.

Cox regression results a with revision of either cup or stem as endpoint, for cemented prosthesis brand combinations inserted 1998–2007 (n = 37,577)

0–10-year follow-up Revision % 6–10-year follow-up
Cause of revision Prosthesis No. revised RR 95% CI p-value 8-year 95% CI No. revised RR p-value
All causes
 Charnley 324 1 2.7 2.3–3.1 45 1
 Exeter 170 1.6 1.3–2.1 < 0.001 5.2 4.0–6.4 40 3.2 < 0.001
 Reflection b/Spectron-EF 190 1.6 1.3–1.9 < 0.001 6.0 4.5–7.4 38 5.2 < 0.001
 Titan 104 1.8 1.4–2.2 < 0.001 4.9 3.9–6.0 15 2.0 0.03
 Spectron/ITH 11 1.1 0.5–2.3 0.8 2.6 0.6–4.6 5 2.0 0.2
 IP/SP (I, II) c 38 1.4 1.0–2.0 0.08 3.0 1.9–4.1 3 0.3 0.3
 Contemporary/Exeter 16 1.1 0.6–1.8 0.8 d d 0 d d
 Kronos/Titan 48 1.9 1.4–2.6 < 0.001 5.4 3.6–7.2 11 3.4 < 0.001
 Elite/Titan 35 2.1 1.5–3.0 < 0.001 d d 11 9.8 < 0.001
 Reflectionb/ITH 23 1.2 0.8–1.9 0.4 3.3 1.8–4.8 6 1.8 0.2
Aseptic loosening
 Charnley 77 1 0.7 0.5–0.9 21 1
 Exeter 70 2.4 1.6–3.8 < 0.001 1.6 0.9–2.3 28 3.5 < 0.001
 Reflection b/Spectron-EF 87 3.8 2.7–5.2 < 0.001 3.4 2.1–4.7 35 10 < 0.001
 Titan 41 3.3 2.3–4.9 < 0.001 2.3 1.5–3.1 11 3.3 0.002
 Spectron/ITH 8 1.4 0.6–3.7 0.5 0.7 0.0–1.5 5 2.1 0.2
 IP/SP (I, II) c 5 0.8 0.3–2.1 0.6 0.4 -0.0–0.9 1 0.0 0.5
 Contemporary/Exeter 1 0.7 0.1–4.8 0.7 d d 0 d d
 Kronos/Titan 18 3.2 1.9–5.4 < 0.001 3.1 1.2–5.0 7 4.8 < 0.001
 Elite/Titan 17 6.2 3.6–11 < 0.001 d d 9 21 < 0.001
 Reflectionb/ITH 11 2.0 1.0–3.8 0.05 1.3 0.3–2.2 6 3.8 0.005

a Revision rate ratios (RRs) and revision percentages with adjustment for sex, age, diagnosis, and cement brand.

b Full brand name: Reflection Cemented All-Poly.

c Full brand name: Link IP/Lubinus SP I (n = 205) and Link IP/Lubinus SP II (n = 1809).

d Less than 50 prostheses at risk.